Testing effectiveness (Phase 2)Study completedNCT03620123
What this trial is testing
Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head and Neck
Who this might be right for
Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCarcinoma, Squamous Cell of Head and Neck
AIO-Studien-gGmbH 54